Search

Your search keyword '"Mikropoulos, Christos"' showing total 146 results

Search Constraints

Start Over You searched for: Author "Mikropoulos, Christos" Remove constraint Author: "Mikropoulos, Christos"
146 results on '"Mikropoulos, Christos"'

Search Results

1. Germline sequencing in men with metastatic castration-resistant prostate cancer from the BARCODE2 study reveals a wide range of pathogenic variants in DNA repair genes

2. Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

3. Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

7. Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

8. Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

9. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

11. Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer—A Retrospective UK Single-Centre Study

15. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

16. Relevance of adjuvant chemotherapy in elderly patients with low rectal tumors.

17. Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls

20. Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants.

22. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

25. The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening

26. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT) : initial results from an international prospective study

28. Long‐term survival after low‐dose‐rate brachytherapy for prostate cancer: the Royal Surrey experience.

29. Wise management of ovarian cancer: on the cutting edge

30. The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening.

33. Wise Management of Ovarian Cancer: On the Cutting Edge

34. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

36. Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations

37. Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations

38. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

39. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

40. Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutation carriers: a case-controlled study (SIGNIFY)

41. Real-world experience of trifluridine/tipiracil in patients with metastatic colorectal cancer: A multicenter United Kingdom study.

43. The clinical impact of using complex molecular profiling strategies in routine oncology practice

44. Patterns of relapse in endometrial cancer

45. Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutation carriers: a case-controlled study (SIGNIFY).

46. The clinical impact of using complex molecular profiling strategies in routine oncology practice

47. Erratum: Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

49. Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53mutation carriers: a case-controlled study (SIGNIFY)

Catalog

Books, media, physical & digital resources